Ongoing Disclosure. Each Party will keep the other Party fully-informed about its efforts to Develop Selected LNA Compounds for such Party’s territory, including summaries of all results and data from such Development efforts, and all significant findings and developments. Such disclosures will be made in written reports to the other Party’s representatives on the JSC at least once annually. Without limiting the generality of the foregoing, such reports will contain disclosure of the following:
Appears in 4 contracts
Samples: License and Collaboration Agreement (Enzon Pharmaceuticals Inc), License and Collaboration Agreement (Evivrus, Inc.), License and Collaboration Agreement (Enzon Pharmaceuticals Inc)